Overview
Lisen Lin practices in Fuzhou, China. Their top areas of expertise are Oral Squamous Cell Carcinoma, Glioblastoma, Astrocytoma, and Glioma.
Their clinical research consists of co-authoring 53 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Lisen S. Lin
Is Lisen S. Lin a top-rated expert for Oral Squamous Cell Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Lisen S. Lin is classified as an Experienced expert for Oral Squamous Cell Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Lisen S. Lin participate in research or clinical trials?
Yes. Lisen S. Lin has published 53 articles and abstracts on conditions like Oral Squamous Cell Carcinoma. You can view a list of Lisen S. Lin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AstrocytomaLin isExperienced. Learn about Astrocytoma.
- GlioblastomaLin isExperienced. Learn about Glioblastoma.
- GliomaLin isExperienced. Learn about Glioma.
- Gliomatosis CerebriLin isExperienced. Learn about Gliomatosis Cerebri.
- Oral Squamous Cell Carcinoma